SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Lizhu Weng · Study

Home/Author

Lizhu Weng

1 works· latest 2019· 1 institutionscluster: provisionalORCID 0000-0003-0188-8614

h-index1

i101

Citations52

Works here1

19

Most cited in this library

Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China2019 · 52 citations

Works

1 shown

Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China

Clinical Therapeutics·2019·7 authors

52citations